BIIB Biogen Inc.
Stock · NasdaqGS · United States · Healthcare · US09062X1037
Price
254.46 USD
+2.22%
52-week range
254.46
Low148.51High258.78
Dividend yield—
Market cap36.8B
NowoTrade score
28 Grade A
Price history
Daily prices in USD.
Updated 05 Nov 2026 08:25. Information, not advice.
Key data
- Previous close
- 248.93 USD
- Market cap
- 36.8B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
No dividends on record.
Why this score
- Business growth 0.0 / 25
- Quality 0.3 / 25
- Financial strength 18.2 / 20
- Valuation 2.7 / 15
- Analysts 4.6 / 10
- Revenue growth of -0.9% a year
- Earnings per share growth of -25.0% a year
- ROE of 2%
- Net debt is 2.0× EBITDA
- Free cash flow yield of 2.2%
- P/E 108.5 against 32.1 for its sector
- Analysts' target is +4% from the price
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Follow BIIB and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.